StoneLab Inc.
StoneLab Inc. is a South Korea-based digital health company that builds AI-driven products spanning digital diagnostics (TESTAR V100, TESTPLUS) and digital therapeutics (ARIA DTx, ARIA Wellness), serving healthcare providers, medical institutions, and patients with mental health conditions.
- Company typePrivate
- Founded2020
- HeadquartersDaejeon, South Korea
- Headcount1–10
- GTM typeB2B and B2C
- OfferingSoftware
What StoneLab Inc. does
StoneLab Inc. is a South Korea-based digital health company founded in 2020 that develops AI-driven solutions spanning digital diagnostics (DDx) and digital therapeutics (DTx). The company operates from its headquarters in Daejeon and a separate AI Research Center in Seoul, targeting enterprise healthcare customers (hospitals, clinics, and medical institutions) and mental health patients with depression or anxiety disorders. Its portfolio sits at the intersection of medical devices, software platforms, and clinical care delivery, addressing both in-vitro diagnostics and prescription digital therapeutics use cases.
The company's technology stack integrates four differentiated AI capabilities: Surface-Enhanced Raman Spectroscopy (SERS) coupled with Optical AI for molecular spectral interpretation in the TESTAR V100 device; a digital diagnostics management platform with AI-powered prediction and simulation in TESTPLUS; generative AI-based auditory stimulation for neuromodulation in ARIA Wellness; and mobile-sensing digital phenotyping combined with Mindfulness-Based Cognitive Therapy in ARIA DTx. TESTAR V100 enables label-free molecular analysis across applications including infectious disease diagnostics, illicit drug screening, antimicrobial resistance testing, and pharmaceutical quality assessment. ARIA DTx is positioned as a prescription digital therapeutic for major depressive disorder and generalized anxiety disorder, integrating hybrid cognitive behavioral therapy with auditory stimuli-based neuromodulation and telemedicine. The four products are accompanied by a supporting services layer of AI Analytics, AI Prediction, AI Interpretation, Data Visualization, and Data Processing.
StoneLab employs a B2B sales-led go-to-market motion with distribution through direct enterprise sales for institutional customers. Stated revenue mechanics span hardware sales of the TESTAR V100 diagnostic device, recurring software subscriptions for the TESTPLUS platform, and managed telemedicine-linked services for prescription digital therapeutics. The company maintains a regional presence exclusively in South Korea. No revenue figures, funding history, named customers, management team, patents, regulatory clearances, certifications, or named partnerships were disclosed in the available data, representing significant gaps for investor due diligence.
StoneLab Inc. firmographics
Firmographics- Name
- StoneLab Inc.
- Legal name
- StoneLab Inc.
- Website
- https://www.stonelab.kr/
- Company type
- Private
- Founded year
- 2020
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- StoneLab Inc. is a South Korea-based digital health company that builds AI-driven products spanning digital diagnostics (TESTAR V100, TESTPLUS) and digital therapeutics (ARIA DTx, ARIA Wellness), serving healthcare providers, medical institutions, and patients with mental health conditions.
- Ownership category
- akta.pro rank
StoneLab Inc. industry classification
Industry- Product category
- Digital Health
- NAICS
- In-Vitro Diagnostic Substance Manufacturing (325413), Research and Development in Biotechnology (except Nanobiotechnology) (541714), Scientific Research and Development Services (5417)
- SIC
- In Vitro & In Vivo Diagnostic Substances (2835), Surgical & Medical Instruments & Apparatus (3841), Pharmaceutical Preparations (2834)
- akta.pro primary industry
- Behavioral Health & Neurocognitive Therapeutics (Digital) (HLACANAI)
- akta.pro secondary industries
- SaMD – Digital Biomarkers & Algorithmic Endpoints (HLACANAF), SaMD – Imaging & Signal Analysis (AI/ML) (HLACANAG)
Keywords
Where StoneLab Inc. is headquartered
LocationHeadquarters
- HQ city
- Daejeon
- HQ country
- South Korea
- HQ region
- Asia
Offices2 records
Markets served
StoneLab Inc. business model
Business model- GTM type
- B2B and B2C
- Offering type
- Software
- Cost components
- Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure
Revenue model
- Medical Device and Diagnostics Hardware Sales: Sale of TESTAR V100 molecular testing device and related IVD equipment for point-of-care testing applications.
- Software Platform Subscriptions: Digital Diagnostics Management Platform (TESTPLUS) and digital therapeutics solutions (ARIA DTx, ARIA Wellness) likely offered as software subscriptions.
- Prescription Digital Therapeutics: ARIA DTx connects clinical experts and patients for telemedicine-based mental health disorder treatment management, suggesting telemedicine service revenue.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels3 records
StoneLab Inc. product offering
Product offeringCore offering
StoneLab Inc. develops and sells AI-powered molecular diagnostic platforms (TESTAR V100, TESTPLUS) for medical institutions and healthcare providers, alongside digital therapeutic products (ARIA Wellness for non-prescription mental wellness, ARIA DTx for prescription digital therapeutics delivered via telemedicine). The company combines AI diagnostic technology with software-based therapeutic delivery across both B2B and B2C channels.
Product overview
StoneLab offers a multi-product AI healthcare portfolio spanning digital diagnostics and digital therapeutics. The product suite includes: (1) TESTAR V100, a Raman Spectroscopy-Optical AI molecular testing solution for IVDx and PDx applications; (2) TESTPLUS, a Digital Diagnostics management platform for real-time POCT data aggregation; (3) ARIA Wellness, a non-prescription mental well-being solution using generative AI neuromodulation; and (4) ARIA DTx, a prescription-based digital therapeutic for mental health disorders combining CBT with neuromodulation. Supporting services include AI Analytics, AI Prediction, AI Interpretation, Data Visualization, and Data Processing.
Differentiator
Problem solved
Functional benefit
Brands
- TESTAR V100: Raman Spectroscopy-Optical AI Integrated Molecular Testing Solution for IVDx and PDx. Captures and interprets molecular spectral signatures with high sensitivity and resolution for applications including illicit drug screening, infectious disease diagnostics, antimicrobial resistance testing, biomarker analysis, drug substance verification, and pharmaceutical quality assessment.
- TESTPLUS
- ARIA Wellness
- ARIA DTx
Products and services
- TESTAR V100 AI-driven molecular diagnostic device/system designed for medical institutions to support clinical diagnostic workflows.
- TESTPLUS Diagnostic platform for healthcare providers offering AI-enabled testing and analysis capabilities.
- ARIA Wellness Non-prescription mental wellness application for the general public, providing self-guided digital mental wellness support.
- ARIA DTx Prescription-based digital therapeutic delivered to patients via telemedicine and clinical experts.
Companies that use StoneLab Inc.
Customer profileSegments3 records
Ideal customer profiles2 records
StoneLab Inc. technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability8 records
Feature7 records
StoneLab Inc. partnerships and signals
Strategic signalScale indicators1 record
Recent moves6 records
Expansion highlights6 records
StoneLab Inc. competitors and assessment
Company assessmentDirect peers
- Akili Interactive: US-based prescription digital therapeutics company focused on cognitive and mental health indications. Directly comparable to StoneLab's ARIA DTx in targeting regulated, clinically validated mental-health DTx with software-delivered therapy.
- Big Health: Digital therapeutics company offering FDA-cleared products for insomnia and anxiety, with employer and payer distribution. Comparable to StoneLab's ARIA DTx in mental-health DTx with enterprise healthcare distribution.
- Woebot Health: AI-driven conversational mental health platform delivering CBT-based therapy digitally. Comparable to StoneLab's ARIA DTx in combining AI with evidence-based psychotherapy delivered through a digital channel.
- Headspace Health: Digital mental health platform combining meditation, CBT and coaching, with employer and payer channels. Comparable to StoneLab's ARIA Wellness and ARIA DTx in evidence-based digital mental-health delivery.
Broad incumbents
- Horiba Scientific: Global manufacturer of Raman spectroscopy and laboratory analytical instruments with applications in life sciences and diagnostics. Comparable to StoneLab's TESTAR V100 as a Raman-spectroscopy-based analytical platform.
- Thermo Fisher Scientific: Global leader in laboratory analytical instruments and in-vitro diagnostics. Comparable to StoneLab's TESTAR V100 and TESTPLUS in providing instruments and platforms for clinical and research molecular diagnostics.
Emerging players
- Renishaw: Provider of Raman spectroscopy instruments and analytical solutions for life sciences and clinical research. Comparable to StoneLab's TESTAR V100 in Raman-based molecular analysis for diagnostics and pharmaceutical applications.
- Pear Therapeutics: Historical US pioneer of prescription digital therapeutics across mental health and addiction indications. Comparable to StoneLab's ARIA DTx as a reference point for prescription DTx business models, regulatory pathways and reimbursement strategy.
Market position
Competitive moat4 records
Key risks6 records
Key highlights6 records
Customer concentration
StoneLab Inc. social profiles
Digital presenceStoneLab Inc. financial estimates
Financial estimateRevenue estimate
Valuation estimate
StoneLab Inc. leadership team
Management profileNumber of profiles
StoneLab Inc. funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
StoneLab Inc. M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about StoneLab Inc.
What does StoneLab Inc. do?
StoneLab Inc. develops and sells AI-powered molecular diagnostic platforms (TESTAR V100, TESTPLUS) for medical institutions and healthcare providers, alongside digital therapeutic products (ARIA Wellness for non-prescription mental wellness, ARIA DTx for prescription digital therapeutics delivered via telemedicine). The company combines AI diagnostic technology with software-based therapeutic delivery across both B2B and B2C channels.
Is StoneLab Inc. a public or private company?
StoneLab Inc. is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was StoneLab Inc. founded?
StoneLab Inc. was founded in 2020. It employs 1 to 10 people.
Where is StoneLab Inc. based?
StoneLab Inc. is headquartered in Daejeon, South Korea, in the Asia region.
How does StoneLab Inc. make money?
Three revenue lines are on record. Medical Device and Diagnostics Hardware Sales are the primary driver. The others are software Platform Subscriptions and prescription Digital Therapeutics.
Who are StoneLab Inc.'s main competitors?
Direct peers on record are Akili Interactive, Big Health, Woebot Health and Headspace Health. Broad incumbents are Horiba Scientific and Thermo Fisher Scientific. Emerging players are Renishaw and Pear Therapeutics.
Does StoneLab Inc. have an API?
No public API is recorded for StoneLab Inc..
What industry is StoneLab Inc. in?
StoneLab Inc.'s product category is Digital Health. Its primary akta.pro industry code is HLACANAI, Behavioral Health & Neurocognitive Therapeutics (Digital), with a secondary code of HLACANAF, SaMD – Digital Biomarkers & Algorithmic Endpoints. Its NAICS code is 325413 and its SIC code is 2835.